ARTMS/Odense University Hospital to Present Solid Target Gallium-68 Production Record at European Association of Nuclear Medicine
Utilizing the ARTMS QUANTM Irradiation System (QISTM) and collaborating with scientists and clinical researchers from the Odense University Hospital (OUH) and the University of Southern Denmark, ARTMS Products Inc, has demonstrated record gallium-68 (68Ga) production levels from a single, short-duration irradiation of QUANTM 68Zn Target Plates.
Dr. Paul Schaffer, founder and CTO of ARTMS, will present “Multi-Curie Production of Gallium-68 on a Biomedical Cyclotron” during the 305 – M2M - Radionuclide Production session at the upcoming European Association of Nuclear Medicine conference being held October 12-16 at the CCIB – Centre de Convencions International de Barcelona in Barcelona, Spain.
Date & Time: Sunday, October 13, 2019: 11:30-12:45
Location: Lecture Hall 111
“ARTMS’ award-winning technology continues to revolutionize the nuclear medicine industry by enabling global access to cyclotron-produced medical isotopes”, said Dr. Schaffer. “I am excited to present these new data produced on the ARTMS QISTM hardware and target plate system.”
“Multi-curie production levels of 68Ga, a much sought after and valuable isotope for medical imaging in prostate and neuroendocrine tumours, is an incredibly important development in nuclear medicine”, noted Assoc. Prof. Helge Thisgaard, OUH and University of Southern Denmark.
“We are incredibly pleased to demonstrate the 68Ga production record using our QISTM technology, hardware and target plate system”, remarked Charles S. Conroy, CEO of ARTMS. “Having already proven the concept and clinical application for routine and high-yield production of 99mTc, ARTMS continues to drive global commercialization and adoption of utilizing the QISTM for production of 68Ga, 89Zr and 64Cu. This is another success reinforcing ARTMS as the global leader in the innovation and commercialization of novel technologies that enable cyclotron production of the world’s most needed medical radioisotopes”.
In addition to the presentation, ARTMS will be hosting an exhibitor booth (#78) at the conference. Attendees are invited to meet with ARTMS representatives during exhibit hours.
For further information or to schedule a meeting, please contact:
ARTMS
Email: info@artms.ca
Phone: 604-228-4016
About Department of Nuclear Medicine, Odense University Hospital, Denmark
Department of Nuclear Medicine is an interdisciplinary clinical department without beds. The department comprises three units: Clinical Physiology, Nuclear Medicine, and the PET and Cyclotron Unit, and it primarily serves within four main areas: routine examinations and therapy, education, research & development.
Activities include functional tests and molecular imaging of most tissues and organs as part of diagnosis, choice and control of treatment, and prognosis assessment in a variety of diseases. The staff comprises approximately 85 employees and the department is equipped with 4 gamma cameras, 4 SPECT/CT scanners, 5 PET/CT and 1 PET/MR scanners as well as two cyclotrons and radiochemical laboratories for routine production and development of a variety of PET tracers. The department receives patients from hospitals and general practitioners on the island of Funen and surrounding minor islands, as well as in the Region of Southern Denmark (1.2 million inhabitants).
About ARTMS
Based in Vancouver, British Columbia, ARTMS Products Inc. is a leader in the development of novel technologies and products which enable the production of the world’s most-used diagnostic imaging isotope, technetium‐99m (Tc‐99m), using local, hospital-based medical cyclotrons. In addition to Tc-99m, ARTMS has developed advanced solutions for the supply of gallium-68 (Ga-68), zirconium-89 (Zr-89) and copper-64 (Cu-64). ARTMS holds the exclusive global commercialization rights to award-winning and proprietary Canadian inventions which address these challenges, and which offer the prospect of revolutionizing the nuclear medicine industry.
For more information on the QUANTM Irradiation System™ and ARTMS Products, please follow us on Twitter @Quantm99 and LinkedIn and visit http://www.artms.ca/.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20191010005144/en/
Contact information
Kamran Shaikh
PR Associates
Email: kshaikh@prassociates.com
778-846-5406
About Business Wire
Business Wire(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
H.I.G. Capital Announces the Sale of DGS S.p.A.11.6.2024 12:00:00 CEST | Press release
H.I.G. Capital (“H.I.G.”), a leading global alternative investment firm with $62 billion of capital under management, is pleased to announce that an affiliate has signed a definitive agreement to sell its portfolio company, DGS S.p.A. (“DGS” or the “Group”), a leading firm in the Italian Information Technology market, to DGS Co-Founders and management team in partnership with ICG, a global alternative asset manager. Since its inception in 1997, DGShas supported blue-chip customers in the design, integration, and maintenance of complex IT systems, with a specialization in digital transformation and cybersecurity services. The Group currently has over 1,900 employees, revenues of approximately €300 million, and maintains a group of highly loyal clientele. During H.I.G.’s ownership, DGS has tripled in size and consolidated its position as a leading Italian firm in cybersecurity services and digital transformation. DGS offers its clients sophisticated and proprietary digital transformation
Evertas Names Nick Selby Head of European Underwriting11.6.2024 12:00:00 CEST | Press release
Evertas, the world’s first crypto insurance company, has named Nick Selby as its new Head of European Underwriting. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240611141887/en/ Nick Selby, Executive Vice President and Head of European Underwriting at Evertas (Photo: Business Wire) Selby, an accomplished information and physical security professional, brings two decades of expertise in public and private sector information security, physical security, and complex incident handling, as well as seven years of experience leading teams securing billions of dollars in cryptoassets. Previously, his roles included VP of the Software Assurance Practice at Trail of Bits, Chief Security Officer at Paxos Trust Company, and Director of Cyber Intelligence and Investigations at the NYPD Intelligence Bureau. “Nick is an extremely valuable addition to our European team,” said Evertas CEO and Co-Founder J. Gdanski. “His public and private
Owlet utvider globalt fotavtrykk med lanseringen av medisinsk-sertifisert Dream Sock™ i Storbritannia og over hele Europa11.6.2024 11:00:00 CEST | Pressemelding
Owlet, Inc. («Owlet» or the «Company») (NYSE:OWLT), pioneren innen smart spedbarnsovervåking, kunngjør i dag den britiske og europeiske lanseringen av Dream Sock. Dette er en smart babymonitor med levende helseavlesninger og varsler for friske spedbarn mellom 0-18 måneder og 2,5-13,6 kg. Dette innovative medisinske utstyret gir foreldre helse og viktig informasjon i sanntid, noe som gir uovertruffen trygghet. Denne pressemeldingen inneholder multimedia. Se hele pressemeldingen her: https://www.businesswire.com/news/home/20240611820341/no/ (Photo: Business Wire) «Vi er svært stolte over å lansere Dream Sock til omsorgspersoner over hele Storbritannia og Europa og gi millioner av foreldre mer trygghet mens babyen sover,» sa Kurt Workman, Owlets administrerende direktør og medgründer. «Dream Sock er nå et globalt produkt som er anerkjent som medisinsk nøyaktig og trygt, etter å ha gjennomgått regulatoriske autorisasjoner og sertifiseringer innenfor flere geografier. I dag er misjonen vår
V-Nova Surpasses 1000 Patent Milestone in Media Technology Innovation11.6.2024 10:00:00 CEST | Press release
V-Nova, a leading provider of data compression solutions, video compression technology, XR technology, AI acceleration and parallel processing for a multitude of industries including media and entertainment, today announced its milestone achievement of 1000 active technology patents. This accomplishment underscores V-Nova’s dedication to research and development and its commitment to protecting its intellectual property globally. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240611724561/en/ V-Nova’s patent portfolio spans more than 50 different jurisdictions. Including over 400 patents in Europe, over 200 in the Americas, over 100 in the United States specifically, and over 200 in Asia. V-Nova forged new directions in data processing to enhance digital experiences, maximize efficiency, reduce costs, and increase sustainability. The company leads the way with key international data compression standards for the video indust
Alipay+ Reveals Top Scorer Trophy Design for UEFA EURO 2024™11.6.2024 09:24:00 CEST | Press release
Alipay+, a suite of cross-border mobile payment and digitalization technology solutions operated by Ant International and an Official Partner of UEFA EURO 2024™, today revealed the trophy that will be awarded to the most prolific marksman at the UEFA EURO 2024™ finale on July 14 in Berlin, Germany. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240610328619/en/ The UEFA Top Scorer Trophy presented by Alipay+ is unveiled for UEFA EURO 2024™ (Photo: Business Wire) Sculpted in the shape of the Chinese character “支” (pronounced zhi, and meaning payment as well as support), the trophy reflects Alipay+’s dedication to supporting consumers to enjoy seamless payment and a broad choice of deals using their preferred payment methods while traveling abroad. The character also resembles the fleeting moment of a barefooted striker poised to shoot, evoking the original beauty and power of football – a game that united people across the wo